Day: March 9, 2015

First Copycat Biotech Drug Spurs $250B Obamacare Savings The first U.S. approval of the “generic” biologic prescription version of the widely prescribed anti-infective cancer medicine Neupogen officially opens the door to a new era in cheaper drugs that could save… Continue Reading →

$10 Copy of Gilead Blockbuster Sovaldi Appears in Bangladesh (Bloomberg) — A $10 version of Sovaldi, the Gilead Sciences Inc. hepatitis C treatment that sells for $1,000 a pill in the U.S., is now available in Bangladesh and could make… Continue Reading →